Loved seeing some old friends in a new place at Virginia Society of Rheumatology! What a fantastic talk as always! @DidemSayginMD
It was such a pleasure to talk about #myositis at Virginia Society of Rheumatology and catch up with friends!
1
6
515
Aditi Patel retweeted
It was such a pleasure to talk about #myositis at Virginia Society of Rheumatology and catch up with friends!
Dr. Didem Saygin @DidemSayginMD discussing “Current Approach to Diagnosis and Management of Inflammatory Myopathy” at VSR.
It’s been a long time coming (I may be singing the tune in my head)…
Excited to share our review in @LancetRespirMed on Idiopathic inflammatory myopathies related lung disease in adults
@sameepsehgal9 @DidemSayginMD
sciencedirect.com/science/ar…
Aditi Patel retweeted
Replying to @ClevelandClinic
@ClevelandClinic #ccfhm23 Continues!
@draditipatel presenting Rheumatologic Emergencies!
@whinnec @MoMohmandMD
Aditi Patel retweeted
Pattern of inflammatory poly arthritis matters!!
Another case of AAV was misdiagnosed as SLE because of positive ANA.
We can do better @VasculitisFound @tay_lorkoenig @draditipatel @adil_fethi
Aditi Patel retweeted
❤️🩺🥼🎉🥳💕📚🩺🥼👩🏼⚕️👩🏻⚕️👩🏽⚕️👩🏽⚕️👩🏾⚕️👩🏿⚕️🧑🏻⚕️🧑🏼⚕️🧑🏾⚕️🧑🏿⚕️👨🏽⚕️👨🏼⚕️👨🏻⚕️👨⚕️👩🏻🔬🧑🔬🧑🏾🔬🧑🏿🔬❤️🥼🩺📚🥇🍨🤳To all the residents for whom I’ve had the tremendous honor to train, I thank you, cherish you & miss you! Happy #ThankAResident Day!! My deepest thanks for your commitment, sacrifice, selfies & hard work! #MedEd
Aditi Patel retweeted
Vascular Ehlers Danlos Syndrome (VEDS)
⭐️ Lack of type 3 collagen leading to vascular catastrophes (dissections, ruptures)
⭐️ Vast majority of patients aren’t recognized until after 1st event
🧵 on when to suspect it and catch it sooner!
#EDS @TheEDSociety #hypermobility
Aditi Patel retweeted
DERMATOMYOSITIS (DM)
Let’s spend some time in this #tweetorial on the dermatologic manifestations of this potentially paraneoplastic disease!
First, a question: What is necessary to make a diagnosis of DM?
1/
35%Muscle biopsy
12%Skin biopsy
20%+ Autoantibodies
33%None of the above
3,046 votes • Final results Aditi Patel retweeted
Patel @draditipatel et al. Delay in starting ACE-I in Scleroderma Renal Crisis increased need for dialysis 75.6% vs 16.7%, p=0.023. No effect on overall survival. 5-year mortality 70%, 1 year mortality 58%. @RheumNow #ACR22 Abstr#1530 acrabstracts.org/abstract/sc…
⭐️Thyroid abn (check TSH, fT3, T4) can mimick inflammatory myositis, biopsy can also show necrosis
⭐️ Rimmed vacuoles are not specific for IBM
⭐️ Finger flexion weakness can be seen in IBM, sarcoidosis, amyloidosis and genetic causes
#ACR22 @kinanah9 @MelanyGonzaOrta @KomalEj
4
Aditi Patel retweeted
Diastolic dysfunction, PHTN, and troponin leak are all may present in SSc #ACR22 @draditipatel
Aditi Patel retweeted
Truly scleroderma is one of the most devastating disease that we encounter in clinic #ACRM2022 @draditipatel
Hearing both sides of whether to treat preclinical RA or not with DMARDs. That role play was just fantastic and real life scenario in our clinica @Janetbirdope #ACR22 #GreatDebate
2
My two favorite rheum fellows guiding me since residency and to ♾️ !! @CCalabreseDO @LisaZickuhr #CleClinicRheu #ACR22
@abbyWUim I got your hug-sending you a big hug right back ❤️❤️!!!
These two powerhouses in one frame! @LisaZickuhr @RulaHajjAliMD. The warm hugs after a virtual madness adds so much ❤️
Aditi Patel retweeted
@CleClinicMD Carol Langford starts the Clinical Review!! #ACR23 @CCalabreseDO @AdamJBrownMD @PerryFuchsMD @ELittlejohnDO
Congratulations @kinanah9 on your well deserved accomplishment. Thanks for your continued teaching not only for our trainees but your colleagues too!

































